EGFR and non-small cell lung carcinoma: The mutational landscape of NSCLC reveals distinct molecular subtypes, with EGFR mutations being the most prevalent driver alterations, particularly in Asian populations (Kobayashi et al., 2023; Zhou et al., 2021).